Search research articles
Contact Us
Filters
Showing results (81-90 of 94) with videos related to
Page
of 10
Sort By:
Metallomics : Integrated Biometal Science
|
October 22, 2022
Single-cell and bulk ICP-MS investigation of accumulation patterns of Pt-based metallodrugs in cisplatin-sensitive and -resistant cell models
Si Ying Lim, Zhi En Low, Regina Pei Woon Tan, et al.
Carbon
|
May 21, 2019
Carbon nanotube bottles for incorporation, release and enhanced cytotoxic effect of cisplatin
Jian Li, Siew Qi Yap, Sia Lee Yoong, et al.
Journal of the American Chemical Society
|
February 24, 2025
Leveraging Immunogenic Cell Death to Enhance the Immune Response against Malignant Pleural Mesothelioma Tumors
Meng Rui Chang, Egor M Matnurov, Chengnan Wu, et al.
Biomolecules
|
September 23, 2020
Triapine Derivatives Act as Copper Delivery Vehicles to Induce Deadly Metal Overload in Cancer Cells
Kateryna Ohui, Iryna Stepanenko, Iuliana Besleaga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 5, 2020
PIPAC-OX: A Phase I Study of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy in Patients with Peritoneal Metastases
Guowei Kim, Hon Lyn Tan, Raghav Sundar, et al.
Current Medicinal Chemistry
|
September 25, 2013
P-glycoprotein and vacuolar ATPase synergistically confer anthracycline resistance to fission yeast and human cells
Zoey Tay, Seok Hwee Koo, Trang Thi Thuy Nguyen, et al.
Nature Communications
|
March 19, 2014
Ligand substitutions between ruthenium-cymene compounds can control protein versus DNA targeting and anticancer activity
Zenita Adhireksan, Gabriela E Davey, Pablo Campomanes, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 22, 2019
A structure-based mechanism of cisplatin resistance mediated by glutathione transferase P1-1
Anastasia De Luca, Lorien J Parker, Wee Han Ang, et al.
Molecular Pharmaceutics
|
August 20, 2011
Characterization of new potential anticancer drugs designed to overcome glutathione transferase mediated resistance
Katarina Johansson, Mika Ito, Carolien M S Schophuizen, et al.
Chemical Reviews
|
September 23, 2025
Colorectal Cancer at the Crossroads: The Good, the Bad, and the Future of Platinum-Based Drugs
Jia Xuan Kee, Jia Ning Nicolette Yau, Ram Pravin Kumar Muthuramalingam, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 94) with videos related to
Sort By:
Page
of 10
Metallomics : Integrated Biometal Science
|
October 22, 2022
Single-cell and bulk ICP-MS investigation of accumulation patterns of Pt-based metallodrugs in cisplatin-sensitive and -resistant cell models
Si Ying Lim, Zhi En Low, Regina Pei Woon Tan, et al.
Carbon
|
May 21, 2019
Carbon nanotube bottles for incorporation, release and enhanced cytotoxic effect of cisplatin
Jian Li, Siew Qi Yap, Sia Lee Yoong, et al.
Journal of the American Chemical Society
|
February 24, 2025
Leveraging Immunogenic Cell Death to Enhance the Immune Response against Malignant Pleural Mesothelioma Tumors
Meng Rui Chang, Egor M Matnurov, Chengnan Wu, et al.
Biomolecules
|
September 23, 2020
Triapine Derivatives Act as Copper Delivery Vehicles to Induce Deadly Metal Overload in Cancer Cells
Kateryna Ohui, Iryna Stepanenko, Iuliana Besleaga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 5, 2020
PIPAC-OX: A Phase I Study of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy in Patients with Peritoneal Metastases
Guowei Kim, Hon Lyn Tan, Raghav Sundar, et al.
Current Medicinal Chemistry
|
September 25, 2013
P-glycoprotein and vacuolar ATPase synergistically confer anthracycline resistance to fission yeast and human cells
Zoey Tay, Seok Hwee Koo, Trang Thi Thuy Nguyen, et al.
Nature Communications
|
March 19, 2014
Ligand substitutions between ruthenium-cymene compounds can control protein versus DNA targeting and anticancer activity
Zenita Adhireksan, Gabriela E Davey, Pablo Campomanes, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 22, 2019
A structure-based mechanism of cisplatin resistance mediated by glutathione transferase P1-1
Anastasia De Luca, Lorien J Parker, Wee Han Ang, et al.
Molecular Pharmaceutics
|
August 20, 2011
Characterization of new potential anticancer drugs designed to overcome glutathione transferase mediated resistance
Katarina Johansson, Mika Ito, Carolien M S Schophuizen, et al.
Chemical Reviews
|
September 23, 2025
Colorectal Cancer at the Crossroads: The Good, the Bad, and the Future of Platinum-Based Drugs
Jia Xuan Kee, Jia Ning Nicolette Yau, Ram Pravin Kumar Muthuramalingam, et al.
Page
of 10